Brean Murray Upgrades Palomar Medical (PMTI) to Buy; JNJ Pullout Creates Buying Opportunity
Brean Murray upgrades Palomar Medical (Nasdaq: PMTI) to Buy. Price target $18.
Brean analyst says, "Johnson&Johnson (NYSE: JNJ) withdrawal not a complete disappointment; Entry point offers more positive long-term opportunities."
To see more analyst ratings on PMTI Click Here.
Palomar Medical Technologies, Inc., along with its subsidiaries, designs, manufactures, markets, and sells lasers and other light-based products, and related disposable items and accessories for use in medical and cosmetic procedures.
Related Categories
UpgradesStocks Mentioned
Related Entities
Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

FUTURE ERNINGS
ALTH on Oct 20, 2009 06:29 AMHOW WILL MY SHARES MAKE MONEY ON THIS STOCK?